Related Experiment Video
Updated: Aug 9, 2026
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity
M Karakantza1, G L Theodorou, A Mouzaki
1Laboratory Haematology and Transfusion Medicine, Medical School, University of Patras, Patras, Greece. makara@med.upatras.gr
Insights
Splenectomy impacts cellular immunity long-term, altering T-cell populations and cytokine production. This study reveals persistent T-cell priming, potentially explaining immune response defects in splenectomized individuals.
Area of Science:
- Immunology
- Cellular Biology
Background:
- The spleen plays a crucial role in immune surveillance and response.
- Understanding the long-term effects of splenectomy on cellular immunity is vital for patient management.
Purpose of the Study:
- To investigate the long-term effects of splenectomy on cellular immunity, specifically focusing on T-cell phenotypes and cytokine production.
- To analyze changes in CD4+ and CD8+ T lymphocytes post-splenectomy.
Main Methods:
- Analysis of peripheral blood T-cell populations (CD4+, CD8+, T-cell receptor gamma/delta) in 22 post-traumatic splenectomy patients.
- Assessment of type 1 (interferon-gamma, IL-2) and type 2 (IL-4, IL-10) cytokine production.
- Stimulation with Staphylococcal enterotoxin B to evaluate T-cell responsiveness.
Main Results:
- Splenectomy led to a long-term reduction in CD4+CD45RA+ cells and a late increase in T-cell receptor gamma/delta cells.
- Normal IL-2 production by CD4+ T cells indicated preserved naive cell function.
- Long-term priming of both CD4+ and CD8+ T cells was observed, with type 1 CD4+ and CD8+ T-cell priming persisting longer.
- Type 2 CD4+ T-cell priming decreased over time, while type 1 CD4+ T-cell priming remained detectable.
Conclusions:
- Splenectomy causes lasting alterations in cellular immunity, including T-cell priming.
- Persistent type 1 T-cell priming may contribute to impaired immune responses to recall antigens in splenectomized individuals.
- Dynamic changes in primed CD4+ T cells over time could be relevant to conditions like autoimmune thrombocytopenia relapse.
Abstract:
The purpose of this study was to investigate the effect of splenectomy on cellular immunity. We studied the cellular phenotype and type 1 [interferon-gamma, interleukin-2 (IL-2)] and type 2 (IL-4 and IL-10) cytokine-producing peripheral blood CD4+ and CD8+ T lymphocytes in 22 healthy adults who had undergone post-traumatic splenectomy about 1 to 35 years ago. Splenectomy resulted in a long-term reduction of the percentage of CD4+CD45RA+ cells and a late increase of the percentage and absolute numbers of T-cell receptor gamma/delta cells. Stimulation with Staphylococcal enterotoxin B resulted in normal IL-2 production by CD4+ T cells, indicating that the naïve cells were not anergic. Splenectomy also resulted in long-term priming of both CD4+ and CD8+ T cells. During the first 8 years, both type 1 and type 2 CD4+ T cells were primed to varying degrees. About 8 years later, the percentage of primed type 2 CD4+ T cells subsided, but that of type 1 CD4+ T cells, although decreased, remained detectable over a longer period. Priming of CD8+ T cells persisted throughout the study period. The long-term priming of type 1 CD4+ and CD8+ T cells, which may result in partial impairment of T-cell functions, may explain reported defects of immune responses to recall antigens in splenectomized individuals. In addition, changes in the profile of primed CD4+ T cells with time may be clinically relevant to relapses in autoimmune thrombocytopenia after splenectomy.
